mTORC1 Couples Nucleotide Synthesis to Nucleotide Demand Resulting in a Targetable Metabolic Vulnerability-Reference-Cited by-同舟云学术

mTORC1 Couples Nucleotide Synthesis to Nucleotide Demand Resulting in a Targetable Metabolic Vulnerability

Published:2017-11 Issue:5 Volume:32 Page:624-638.e5
ISSN:1535-6108
Container-title:Cancer Cell
language:en
Short-container-title:Cancer Cell

Author:

Valvezan Alexander J.,Turner Marc,Belaid Amine,Lam Hilaire C.,Miller Spencer K.,McNamara Molly C.,Baglini Christian,Housden Benjamin E.,Perrimon Norbert,Kwiatkowski David J.,Asara John M.,Henske Elizabeth P.,Manning Brendan D.

Funder

American Cancer Society

LAM Foundation

The Engles

NIH

Publisher

Elsevier BV

Subject

Cancer Research,Cell Biology,Oncology

Reference59 articles.

1. Therapeutic trial of metformin and bortezomib in a mouse model of tuberous sclerosis complex (TSC);Auricchio;PLoS One,2012

2. Myc-dependent purine biosynthesis affects nucleolar stress and therapy response in prostate cancer;Barfeld;Oncotarget,2015

3. Purification of ribosomes from human cell lines;Belin;Curr. Protoc. Cell Biol.,2010

4. mTORC1 signaling and the metabolic control of cell growth;Ben-Sahra;Curr. Opin. Cell Biol.,2017

5. Stimulation of de novo pyrimidine synthesis by growth signaling through mTOR and S6K1;Ben-Sahra;Science,2013

Cited by 113 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Inhibition of autophagy as a novel treatment for neurofibromatosis type 1 tumors;Molecular Oncology;2024-08-11

2. Interplay between mTOR and Purine Metabolism Enzymes and Its Relevant Role in Cancer;International Journal of Molecular Sciences;2024-06-19

3. Targeting the ACOD1-itaconate axis stabilizes atherosclerotic plaques;Redox Biology;2024-04

4. The Characteristics of Tumor Metabolism and Its Application Progress in Tumor Therapy;Advances in Clinical Medicine;2024

5. Network pharmacology and metabolomics elucidate the underlying mechanisms of Venenum Bufonis in the treatment of colorectal cancer;Journal of Ethnopharmacology;2023-12